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Abstract
Summary This is a cost-of-illness study of osteoporotic
fractures in Denmark estimating the incremental societal
cost associated with osteoporotic fractures, with both direct
cost and productivity cost. This study includes cost regard-
ing hospitals, general practices, the patients, the municipal-
ities and regions. The total cost of osteoporotic fractures in
Denmark was estimated at EUR 1.563 billion.
Purpose The aim of this study is to estimate the societal
burden imposed by osteoporotic fractures in Denmark. In
contrast to prior studies, this study will present a compre-
hensive model for the cost of osteoporotic fractures regard-
ing hospitals, general practices, the municipalities, the
regions and the patients.
Methods This cost-of-illness study applied an incidence-
based bottom-up approach from a societal perspective, includ-
ing both direct costs and productivity costs. The study focused
on incremental cost associated with osteoporotic fractures
using a Markov model. Danish citizens ≥50 years with an
osteoporotic fracture between 2001 and 2010 were studied.
Results The total cost of osteoporotic fractures in Denmark
was estimated to EUR 1.563 billion in 2011, at EUR 628
million and EUR 936 million for men and women, respec-
tively. The most expensive fracture for both genders was
first hip fracture. The municipalities carried the majority of
the costs, with 55–57 % of incremental lifetime cost.
Conclusions This study showed that the incremental socie-
tal burden of osteoporotic fractures is an important health
problem. Medical costs of the osteoporotic fractures were
substantial cost for the health care sector, but were by far
exceeded by the cost for the municipality in terms of social
services and rehabilitation.
Keywords Costs and cost analysis . Osteoporosis .
Fractures . Bone . Markov . Denmark
Introduction
Osteoporosis is frequent [1], and its consequences, especial-
ly fractures [2–4] and disability [5], constitute a heavy
burden on the health care system and the economy. Patients
with osteoporotic fractures utilize more healthcare services,
thereby imposing increased healthcare costs. Several health
economic studies on the cost of osteoporosis have been
published within the last two decades, especially in Europe
and North America [6–8]. The majority of these are cost-of-
illness studies (COI), which provide estimates cost of oste-
oporosis, but give no guidance on how to allocate resources
to improve efficacy. The information given by COI on the
societal burden of an illness is important for determining the
awareness and attention the illness should be given [9, 10].
Studies on the cost of osteoporosis have primarily focused
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on hospital-related costs, thus no indirect costs are included.
Modelling in health economics has several advantages be-
cause of the ability to extrapolate the results from studies,
combining best evidence from multiple sources, and outline
areas of uncertainty [11].
The aim of this study is to solely estimate the societal
burden imposed by osteoporotic fractures in Denmark. In
contrast to prior studies, this study will present a compre-
hensive model for the cost of osteoporotic fractures regard-
ing hospitals, general practices, the municipalities, the
regions and the patients.
Materials and methods
This COI study applied an incidence-based bottom-up ap-
proach from a societal perspective, including both direct and
productivity costs. This study took form of secondary analysis
of relevant publications and administrative data from different
Danish registers. To solely include osteoporosis-attributable
costs, the incremental costs between osteoporotic patients and
the corresponding background population were incorporated
in the estimations of cost of osteoporotic fractures in Den-
mark. The term direct costs covers the costs of inpatient,
outpatient, rehabilitation, nursing home, respite care, social
services and assistive devices. The costs of productivity loss
resulting from not being able to perform work, early retire-
ment or death were calculated by the human capital approach.
All costs included in the study are given in 2011 prices, and a
gross costing approach has primarily been undertaken.
Systematic literature search
A systematic literature search was performed, in accordance
with PRISMA statement, to identify existing literature on COI
regarding osteoporotic fractures. The search was conducted
on September 25, 2012 in Cochrane Library, Embase,
CINAHL, PubMed, EconLit, SveMed+ and Bibliotek.dk.
Search terms, MeSH if possible, which were relevant to
osteoporosis, fractures, costs and cost of illness, were applied,
and equivalent Danish terms were used to search Bibliotek.dk.
Inclusion criteria for this review were: men and/or women
above 40 years; suffering from primary or secondary osteo-
porosis; hip, vertebral and/or wrist fractures; and cost of
illness. The search identified 1,529 studies, and of these, 24
were identified as relevant. Six additional studies were iden-
tified from references, giving a total of 30 studies.
Model approach
As osteoporosis is a chronic disease with recurrence of
fractures, a Markov state transition model was appropriate
to estimate the total societal cost of osteoporotic fractures in
a Danish population of 50–99 years of age. Most orthopae-
dic surgeons often only diagnose fracture and not the cause
of fracture (e.g. osteoporosis), thus to identify precise esti-
mations of incidence of osteoporosis, fracture occurrence
was combined with age [1]. From Danish literature, it was
estimated that 17.7 and 40.8 % of Danish men and women
over the age of 50 years are at risk of osteoporosis [1]. Thus,
in 2011, the cohort should consist of 149,466 men and
388,474 women, which is the cohort used for Markov
simulation in this study.
A Markov model was constructed and analysed with
TreeAgePro version 2012, TreeAge Software, Inc. The
model simulated the natural history of osteoporotic fractures
by tracking fracture events and costs for the cohorts of
patients as they transition across the ten health states, using
1-year cycles. The health states included in this model were:
well, wrist, post-wrist, vertebral, post-vertebral, first hip,
post-first hip, second hip, post-second hip and death. This
is illustrated in Fig. 1. The post-fracture states were included
to minimise the “memory-less” feature of Markov model-
ling, hence the increased risk of fractures following first
fracture and associated cost were incorporated in the model
simulating the natural history of osteoporotic fractures. All
patients in the cohort were assigned to only one state for
each cycle. The model was limited to maximum two hip
fractures during a lifetime. One model for each gender was
constructed to capture the different cost and probabilities
across genders. Tables were applied for transition probabil-
ities as these may change over time.
All transition probabilities are based on data from The
Danish National Hospital Discharge Register (DNHDR)
combined with relative risks for new fractures [12] and
death [13] and were transformed to gender- and age-
dependent probabilities.
The Markov model will be used to estimate incremental
lifetime cost of fractures discounted back to 2011 for both
genders and this will be divided into cost per health state
Fig. 1 Illustration of the transition possibilities in the Markov model
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and into payer perspective. The calculations for the total
cost of osteoporosis will be based on incremental lifetime
cost and the demographic composition.
Identification of model population
The selected model population was all Danish citizens
≥50 years with an osteoporotic fracture between 2001 and
2010, as osteoporotic fractures most often occur in this age
group [6, 14, 15]. The model population was divided into
different age groups at 5-year intervals, ranging 50–99. An
osteoporotic fracture was defined as wrist fracture (ICD-10:
S52, S52.5B and S52.9), vertebral fractures (ICD-10: S22.0-
S22.1, S32.0-S32.2 and S32.7-S32.8) or hip fractures (ICD-
10: S72, S72.0 and S72.1), as these were considered directly
associated with osteoporosis [2, 3]. For vertebral fractures
however, the true prevalence is expected to be
underestimated, since the majority are morphometric [16].
A Danish study has shown that only 10 % of vertebral
fractures were treated in a hospital, 40 % received pain
relief at own general practitioner (GP) and 50 % were not
diagnosed [17]. Thus, the numbers identified by diagnosis
codes only represent the minority of vertebral fractures,
whereas it must be assumed that all hip fractures and
wrist fractures were diagnosed and treated [18, 19]. In
the Markov model, all vertebral fractures, both those with
and without clinical manifestations, are included. Second
fractures of the wrist and vertebral are not included in this
model, but are considered as a new fractures, as patient spe-
cific data were not available. Furthermore, readmissions were
not possible to exclude as patient-specific data were not
available.
Data sources
In Denmark, all citizens are covered by the national public
health system and all contact to hospitals is free and regis-
tered according to their social security number. All contacts,
both in- and outpatient, are registered in DNHDR, from
which it is possible to locate the incidence of different
diseases, e.g. fractures [19]. Studies investigating the valid-
ity of DNHDR found that the validity of fracture reports was
97 % [18]. From the DNHDR, data on diagnosis and oper-
ation codes were drawn for 2001–2010 to estimate the
incidence of fractures, corresponding treatment and rehabil-
itation [20]. In Denmark, 25 % of wrist fractures were
treated with surgery [17, 21], and 25 % were referred to
physiotherapist [17, 22]. As many vertebral fractures are
undiagnosed, probably only 10 % were registered in
DNHDR [17], hence the remaining fractures and resource
use were estimated based on literature and clinical experts.
In case of hip fracture, 75.4 % of women and 82.3 % of men
were surgically treated using internal fixation methods [4],
and the remaining fractures were treated with alloplastic.
Two kinds of rehabilitation were offered in Denmark with
96.3 % having standard rehabilitation [20]. On average, hip
fracture patients were treated at rehabilitation institutes
2 h/week for 3 months [23].
Furthermore, the length of stay (LOS) for the different
fractures was collected from DNHDR and used to estimate
the productivity loss for the working age group (50–
64 years) (LOS: wrist, 1 day; vertebral, 4 days) [20]. Pro-
ductivity loss following hip fracture was set to 3 months, as
patients were not able to resume their previous activities and
work immediately after discharge from hospital [24]. The
relative risk for new fractures differed between genders and
was estimated based on the literature [12, 25].
In order to calculate age-specific incidence rates for frac-
tures and death, the census database from Statistics Den-
mark was used to retrieve population numbers and deaths
from 2001 to 2010 [26]. Data from Statistics Denmark were
also used for data collection in order to calculate productiv-
ity costs (see Table 1). The risk of dying following a fracture
was retrieved from literature [13, 27, 28].
Prescribed pharmaceuticals in Denmark are registered by
the Danish Medicines Agency. The data cover 100 % of all
prescriptions [29]. In Denmark, the GP must apply for
reimbursement for each patients treated with anti-
osteoporotic pharmaceuticals, except for alendronate in the
case where a patient has had a low energy hip fracture [30].
However, these guidelines were only introduced recently
and may thus have had little effect. It was presumed the
persistence with the initial anti-osteoporotic pharmaceutical
treatment was as stated in Roerholt et al. [31]. Calcium and
vitamin D are neither prescribed nor reimbursed and pur-
chases are thus not registered, so it was assumed that all
patients using prescription pharmaceuticals are taking calci-
um and vitamin D supplement.
The Danish Longitudinal Study of Ageing consists of
data from a national questionnaire survey performed in
1997, 2002 and 2007 on a sample of elderly Danish citizens
aged ≥50 representative of their age groups. The database
features a total of 23,704 completed questionnaires from
13,075 individuals. The three main areas of interest in this
database are everyday life, labour market conditions and use
of government benefits [32]. From this database, informa-
tion regarding incremental use of personal care (16.6 %) and
visits to GP (15.7 %) between osteoporotic and non-
osteoporotic patients were retrieved. Hours per week of
receiving personal care were estimated based on a Danish
governmental report at 3.7 h [33].
Data regarding the use of assistive devices (walker,
reaching aid, toilet raiser, dressing stick, crutch, bed raiser,
bath bench and arthrodesis cushion) were retrieved from
literature [34] and validated by experts. Further, 12 % of
hip fracture patients received food service [34].
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The following unpublished data from Odense University
Hospital were kindly provided by M.D. Jesper Ryg: the
incremental discharge to nursing home (i.e. compared to
average Danish citizens) or discharge to respite care
following hip fracture were 5 % for both. All future costs
applied in the Markov model are discounted at 3 % annually
as recommended by the National Institute for Health and
Clinical Excellence [35].
Table 1 All cost used to estimate cost of fractures, both direct and productivity costs
Cost component Item Unit Costs (EUR) Data source
Direct cost
Inpatient care
Wrist Orthopaedic care 2,189.01 [36]
Emergency room care 224.40
Vertebral PVP 7,507.24 [36]
Medical treatment 3,176.01
Hip Internal fixation 9,945.17 [36]
Pertrochanteric internal fixation 6,327.75
Intracapsular alloplastic surgery 9,216.89
DXA scan 350.27 [36]
GPa Annual consultation 175.82 [37]
Pharmaceuticalsa Men (annual cost) 332.53 [38]
Women (annual cost) 303.83
Rehabilitationa Standard care (hourly cost) 113.84 [23]
At own home 0.00
Respite carea At nursing home (daily cost) 112.09 [44]
Co-payment for patients 15.82
Nursing homea Yearly cost 51,858.98 [44]
Social services
Food service Cost per delivery, municipal 1.60 [40]
Cost per delivery, co-payment 6.30
Personal care Cost per hour 62.26 [40]
Assistive devices
Arthrodesis cushion Purchase price 57.54 [45]
Bath bench Purchase price 107.24 [45]
Bed raiser Purchase price 19.30 [45]
Crutch Purchase price 19.71 [45]
Dressing stick Purchase price 40.48 [45]
Reaching aid Purchase price 13.40 [45]
Toilet raiser Purchase price 58.98 [45]
Walker Purchase price 246.51 [45]
Productivity cost
Productivity lossa
(daily wage per age group)
50–54 Men 219.96 [26]
Women 168.04
55–59 Men 211.51 [26]
Women 159.53
60–64 Men 186.60 [26]
Women 133.16
65 Men 145.15 [26]
Women 102.08
No cost difference between men and women unless otherwise stated
a No cost difference between the types of fracture
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Estimation of costs associated with inpatient care
Hospital costs are accumulated in secondary sector and do
not differ between genders or age groups. Inpatient costs for
the three fracture types were determined from Danish
diagnosis-related group (DRG) browser [36], which contain
information on total reported DRG cases with correspond-
ing ICD-10 diagnoses, cost weights and average LOS [36].
For vertebral fractures, which are not diagnosed, no cost will
be applied. This is illustrated in Table 1.
Estimation of costs associated with GP and pharmaceuticals
GP costs were accumulated in general practice and do not
differ between gender or age groups. These included con-
sultation fee, annual check-up, blood tests and telephone
consultation [37].
Pharmaceuticals included prices for anti-osteoporotic phar-
maceuticals, pain-relieving medication, calcium and vitamin
D. From a calculated weight average purchase price for anti-
osteoporotic pharmaceuticals, a patient would be reimbursed
75 % of purchase price [38]. This is illustrated in Table 1.
Estimation of costs associated with rehabilitation,
respite care and nursing home
Rehabilitation, depending on type of fractures and the patient’s
health state, during admission was included in the DRG. After
admission, rehabilitation takes place at specialized units as
standard rehabilitation or rehabilitation in own home. Respite
care is temporary care, on average 26.8 days after hip fracture
(unpublished data, M.D. Jesper Ryg), at a nursing home facil-
ity for patients needing care after hospitalisation. As many
elderly eventually move to a nursing home, only the incremen-
tal length of stay due to osteoporotic hip fractures was included
in this study. The incremental length of stay at nursing home
was estimated at 2 years, as the average age for moving to
nursing home in general population was 84 years [39] and for
osteoporotic patients it was 82 years (unpublished data, M.D.
Jesper Ryg). Patient co-payment for nursing home was fixed
at 10–20 % of the total costs of stay at nursing home
depending on the personal income. The patient’s co-payment
to food at the nursing home and cost for staying at respite care
was also included. This is illustrated in Table 1.
Estimation of costs associated with social services
and assistive devices
Social services and assistive devices were only included for
hip fracture patients because it was estimated that wrist or
vertebral fracture itself does not increase the need for social
services or assistive devices compared to the general popula-
tion. Cost data of social services was retrieved from the
National Board of Social Affairs including costs of food deliv-
ery and personal care [40]. Personal care is a social service
offered in Denmark and includes help for personal hygiene,
getting dressed, etc. Eight types of assistive device were includ-
ed in the study and costs for assistive devices were estimated
from the municipal suppliers. This is illustrated in Table 1.
Estimation of productivity costs
As a societal perspective was adopted, the cost of absence at
work following osteoporotic fractures was included. The
human capital method was used to estimate the productivity
loss by valuing the time away from the labour market as the
average daily wage in Denmark, according to gender and
age groups [26]. To estimate the productivity losses, the
number of days absent from work due to hospitalisation,
rehabilitation, respite care and nursing home or premature
death (before retirement age at 65 years) was included. Valu-
ation of an average daily income and the labour force partic-
ipation rate for men and women between 50 and 65 years
were estimated from Statistics Denmark [26]. All costs are
illustrated in Table 1. Cost of informal care was not included.
Validation of the Markov model
To assess the assumptions made for the COI model, several
analyses were performed. Firstly, in order to confirm that the
estimated number of fractures were the equivalent to those
modelled by the programme, debugging was conducted.
This debug method was done by applying tracker variables
for the health states first hip, second hip, vertebral and wrist
and comparing this result with the observed incidence from
DNHDR. Secondly, to estimate which costs and probabili-
ties would have the most impact on the COI, a one-way
sensitivity analysis was conducted. For this analysis, inter-
vals of likely best/worst scenarios were applied.
Results
The total cost of osteoporotic fractures in Denmark was
estimated to EUR 1.563 billion in 2011, at EUR 628 million
and EUR 936 million for men and women, respectively. This
number was based on an estimated 149,466 men and
388,474 women at risk of osteoporosis. The total costs for
different age groups are illustrated in Fig. 2. It should be
noted that the peak for both men and women between 50 and
69 years could mainly be explained by productivity costs.
The incremental lifetime costs imposed by osteoporotic
fractures, hence osteoporosis, were EUR 35,714 and EUR
26,152 per person for men and women ≥50 years in 2011,
respectively. Furthermore, the age of 78 years for men and
84 years for women was the most costly.
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Fracture cost
When dividing the incremental lifetime costs into the health
states to investigate the cost of different fracture types, follow-
ing results emerged: First hip fracture was the most expensive
at EUR 13,683 for men and EUR 9,385 for women, equivalent
to 38 and 36 %, respectively, of the incremental lifetime cost
accumulated for osteoporotic patients. Furthermore, well, wrist,
post-wrist and post-vertebral may be considered relatively in-
expensive health states compared to vertebral, post-first hip,
second hip and post-second hip. All results on fracture costs are
illustrated in Table 2.
Who carries the burden?
The incremental lifetime costs of osteoporotic fractures were
divided according to the payer, giving five categories, re-
gional, general practice, municipalities, patient and produc-
tivity cost, which were carried by the employers and
employees (the osteoporotic patients with fractures). The
results are illustrated in Table 3. The municipal held the
majority of incremental lifetime costs associated with oste-
oporotic fractures 55–57 %. Regional costs were associated
with 22 and 25 % of incremental lifetime cost for men and
women, respectively. Patient cost amounts to approximately
7 % for both genders. General practice cost amount to
0.67 % for men and 0.74 % for women. Productivity costs
amount to 14 % for men and 13 % for women.
Validation of model
The one-way sensitivity analysis showed that only few vari-
ables had significant effect on the total incremental lifetime
cost. The following results were true for both genders. From
the analysis, it was observed that the amount of hours of
personal care delivered, when these were varied from 3.4 to
6.55 h per week, changed the result to the highest level. The
second most influential variable in the analysis was the cost
for personal care. For men, the interval for change in incre-
mental lifetime costs was between approximately EUR
31,000 and EUR 46,000, and for women, the interval was
between approximately EUR 22,500 and EUR 33,000.
When performing the debug method on the model,
roughly the same number of fractures was produced as
expected from literature for both men and women. Because
the model favours hip fractures over wrist and vertebral
fractures, the two latter show lower fractures from the model
than expected from DNHDR, while hip fractures are a bit
more frequent than expected from DNHDR.
Table 2 Incremental life time cost per person divided by health states
Health state Men, EUR (%) Women, EUR (%)
Well 42.44 (0.12) 128.85 (0.49)
Wrist 23.62 (0.07) 79.16 (0.30)
Post-wrist 3.32 (0.01) 114.91 (0.44)
Vertebral 2,129.51 (5.96) 2,462.37 (9.42)
Post-vertebral 41.77 (0.12) 479.11 (1.83)
First hip 13,682.59 (38.30) 9,385.04 (35.89)
Post-first hip 9,187.82 (25.73) 5,294.16 (20.24)
Second hip 5,759.17 (16.13) 4,678.48 (17.89)
Post-second hip 4,844.14 (13.56) 3,530.10 (13.50)
Dead 0.00 (0.00) 0.00 (0.00)
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Discussion
The societal burden imposed by osteoporotic fractures in
Denmark in 2011 was estimated at EUR 1.563 billion. This
result was divided according to payers, from which the
Danish municipalities held the majority of the costs (55–
57 % of total cost). Danish regions were the second greatest
payer for osteoporotic fractures in Denmark at 21–25 % of
total cost. When looking at the cost depending on the type of
fracture, the most expensive health states were first hip and
post-first hip accounting for 20–38 % of the total costs. The
incremental lifetime cost imposed by osteoporotic fractures
for men and women ≥50 year in 2011 was 35,714.38 EUR
and 26,152.18 EUR per person, respectively.
Results showed that a man on average was more expensive
than a woman. However, women consumed the highest total
cost. This is because more women than men are at risk of
developing osteoporosis (40.8 vs. 17.7 %) [1] and thus con-
sume a greater total cost. When investigating the different
costs across age groups, the most expensive age group was
75–79 for men and 80–84 years for women. This is a result of
a larger fraction of patients in the expensive fracture or post-
fracture states, compared to earlier age groups. Furthermore,
in the stages after 75 years, the mortality increases for both
gender, why the cost declines as a consequences hereof.
Similar studies have also investigated the cost of frac-
tures. When investigating, e.g. hip fractures, other studies
have shown results within the range of EUR 15,500–50,000
when converted to 2011 prices by consumer price index (for
European countries, harmonized indices of consumer prices
in health care have been used) [6, 14, 15, 41, 42]. This study
showed that the estimated cost of hip fractures was EUR
13,683 for men and EUR 9,385 for women, which also
included productivity cost. Thus, the result from this study
must be considered very conservatively estimated and in the
lower end of the interval compared to other COI studies.
In Denmark, the taxes finance the majority of the health
care system, which includes treatment at hospital, GP, reha-
bilitation, etc. Because health care systems across the world
are organised very differently (except for Scandinavia, UK,
Germany etc. which are somewhat comparable to Denmark),
it may be difficult to compare this study’s results of total cost
from a payer perspective with other studies. However, hidden
costs of osteoporotic fractures must be expected in countries
with different models for the health care system economy, as
well as those with similar organisation as the Danish.
The results of this study can help bring awareness to this
major economic health problem that osteoporotic fractures
constitute. This study is the first of its kind to cover the
national economic burden in Denmark, and it is expected
that the result will increase the attention to the disease, as
several payers are substantially economically involved. The
cost of osteoporotic fractures may earlier has been hidden as
the health care costs of old age are significantly increased,
and by covering the true incremental cost of osteoporotic
fractures, osteoporosis should receive an increased societal
awareness.
When decisions regarding screening or preventive treat-
ments are made by decision makers, both costs and potential
health gains must be considered. The complete societal burden
of osteoporotic fractures should therefore also include quality of
life, as this is an important aspect of patients' well-being. COI
studies from Sweden [6, 9], New Zealand [41] and Germany
[43] show that osteoporosis and osteoporotic fractures impose a
significant loss in quality of life. Thus, it must be expected that
similar findings would be found for the Danish population.
The strengths of this study include the empirical data used
to estimate the number of fractures. Danish registers have a
documented validity for diagnoses, especially fractures.
Gender- and age-specific values have been applied within
the model whenever possible, to include variation that may
exist. Sensitivity analyses have been used to assess which
assumptions would influence the cost of osteoporotic fractures
and to produce validity. This COI study has applied a broad
societal perspective, by including costs for social services,
rehabilitation, nursing home, productivity loss both due to
illness and death, etc. Thus, it must be deduced as a valid
COI study. This should be compared to other COI studies of
osteoporosis that most often only consider hospital perspec-
tive and/or do not include productivity loss.
Conservative estimations in this study may underestimate
the actual societal cost of osteoporotic fractures. First of all, the
study population only included patients above 50 years of age.
However, a few may develop the disease or experience frac-
tures before this age. Furthermore, only osteoporotic fractures
have been used to estimate the societal cost, but these patients
may have unknown expensive co-morbidities. Secondly, the
types of fractures included can with certainty be ascribed
osteoporosis. However, fractures may occur elsewhere but
are not included in this study. This provides an underestimation
of the total cost of osteoporosis, estimated by other COI studies
to constitute approximately 3–19 % [14, 44]. Furthermore, it
cannot be precluded that some of those fractures included are
caused by metastases and should therefore have been eliminat-
ed. Thirdly, the quality of life has not been estimated or valued
for this study population and cost for family caregiver time was
not valued. Other sources than peer-reviewed journals have
been used due to lack of cost data from these. Therefore, other
sources such asDanish scientific articles and consultant reports
have been used when necessary.
This study prove that the increased societal burden of
osteoporotic fractures is substantial at EUR 1.563 billion
and must be acknowledged nationally as an important health
problem. Medical costs of the osteoporotic fractures are
substantial cost for the health care sector, but are by far
exceeded by the cost for the municipal in terms of social
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services and rehabilitation. In fact, the 55 % of the burden of
osteoporotic fractures is carried by the municipalities. The
broad impact of the disease across age and gender under-
lines the need for treatment and awareness to the population
with growing and unrecognized needs.
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